Medical News

RSS

Winners of 2010 Quality and Innovation Awards announced

The Cancer Quality Council of Ontario, Cancer Care Ontario, and the Ontario Division of the Canadian Cancer Society today announced the winners of the 2010 Quality and Innovation Awards.

9 Dec 2010

St. Jude Medical announces advanced technologies for streamlined workflow in EP lab

St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.

9 Dec 2010

Downstream cancer care linked to complications during surgery

Patients who have complications after colorectal cancer surgery are less likely to get chemotherapy, even when it is clearly recommended for their diagnosis, a new study from the University of Michigan Comprehensive Cancer Center finds.

9 Dec 2010

Weightlifting program does not increase risk of lymphedema in breast cancer survivors

A slowly progressive weight lifting program for breast cancer survivors did not increase their risk of lymphedema (arm swelling and discomfort), according to a study that will appear in the December 22/29 issue of JAMA. The study is being released early online to coincide with its presentation at the San Antonio Breast Cancer Symposium.

9 Dec 2010

Research into hospital bed technology could soon represent giant leap forward in patient care

A University of New Hampshire professor's research into hospital bed technology could soon represent a giant leap forward in patient care.

9 Dec 2010

Agilent, UC Davis to develop MassCode PCR technology for identifying food-borne pathogens

Agilent Technologies Inc. today announced it is collaborating with the University of California, Davis in the area of food safety. The research collaboration will focus on the development of a new process that can reduce the time required to identify food-borne pathogens from several days to only a few hours.

9 Dec 2010

Haitian health ministry says more than 2,000 have died from cholera; Report identifies outbreak's source, some dispute findings

More than 2,000 people have died of cholera in Haiti since late October, Haitian officials said on Monday, the Associated Press/Washington Post reports (12/6). According to Haitian health ministry figures, a total of "2,013 people have died from the water-borne bacterial infection and 88,789 cases have been recorded," Agence France-Presse writes (12/6).

9 Dec 2010

Capitol Hill: Upton to lead energy and commerce; Dems unveil budget bill, Senate considers 9/11 worker health bill

The Hill: Rep. Fred Upton (R-Mich.) "is in position to become the next chairman of the powerful House Committee on Energy and Commerce," which puts him in "an enviable position for any House Republican, as he will lead efforts to investigate, repeal and replace the new health care reform law." Upton received the endorsement of the Republican steering committee Tuesday night (Millman, 12/7).

9 Dec 2010

Enbrel outperforms Humira in treating newly diagnosed RA patients: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Amgen/Pfizer's Enbrel is the leading tumor necrosis factor -alpha inhibitor prescribed in newly diagnosed rheumatoid arthritis patients, outpacing Abbott's Humira in the first three lines of treatment.

9 Dec 2010

Teva, Active Biotech report positive initial results from laquinimod Phase III study in multiple sclerosis

Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.

9 Dec 2010

Medisafe 1 Technologies demonstrates syringe locking device at Israel's National Ministry of Health

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company conducted an official demonstration of its barcoded syringe locking device at Israel's National Ministry of Health.

9 Dec 2010

Research findings could lead to new therapies to correct neurological disorders

Yale University researchers have found that a single molecule not only connects brain cells but also changes how we learn. The findings, reported in the December 9 issue of the journal Neuron, may help researchers discover ways to improve memory and could lead to new therapies to correct neurological disorders.

9 Dec 2010

XenoPort prices underwritten offering of common stock

XenoPort, Inc. announced today the pricing of an underwritten offering of 4,000,000 shares of its common stock at a price to the public of $7.15 per share. XenoPort has granted to the underwriters a 30-day option to purchase up to an aggregate of 600,000 additional shares of common stock to cover over-allotments, if any.

9 Dec 2010

Media examines efforts to protect patients in Africa from counterfeit medications

HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. "Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually," according to the article (Zax, 12/6).

9 Dec 2010

Urgent reform of Medicaid-financed community care for ADHD children needed

The enactment of the Patient Protection and Affordable Care Act of 2010 expands Medicare benefits to scores of previously uninsured individuals including many of our nation's children. While access to treatment is laudable, the quality of such treatment is the subject of an article in the December issue of the Journal of the American Academy of Child and Adolescent Psychiatry.

9 Dec 2010

VIRxSYS presents study results of VRX1116 at HIV DART 2010

VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies, today presented results from a study of VRX1116 at HIV DART 2010 in Los Cabos, Mexico, showing that vaccinated monkeys challenged with highly pathogenic simian immunodeficiency virus achieve sustained viral load reduction, preservation of the immune system and increased survival compared to controls.

9 Dec 2010

Dietitians prefer olive oil as food oil of choice

A newly released survey of dietitians, which examines their current perspectives regarding various dietary fats and oils, reveals a strong preference for olive oil as the food oil of choice even for individuals on a diet. Canola oil was the second choice, while other oils—safflower, soybean, peanut, corn and flax—trailed far behind.

9 Dec 2010

Report examines African government funding for child development

Tanzania, Mozambique and Niger spend the most on child wellbeing in Africa - with Sudan, Angola and Burundi at the bottom of the table," according to an African Child Policy Forum report, which was launched in Addis Ababa, Ethiopia, on Tuesday at the opening of the Fourth International Policy Conference on the African Child, Deutsche Presse-Agentur/M&C reports (12/7).

9 Dec 2010

Arizona State Dem. lawmakers push for restoring Medicaid transplant money

The Fiscal Times: "Organ transplants are considered optional by the federal government. And in today's economic climate, 'optional' means endangered. In Arizona, the expenses for transplants are generally covered by the Arizona Health Care Cost Containment System (AHCCCS), or 'Access,' as the state's version of Medicaid is known. But since cash-strapped Arizona is having trouble covering its mandated medical costs—never mind anything else—[some] transplants, among other things, are on the chopping block" (Mackey, 12/7).

9 Dec 2010

European researchers develop new form of therapy for Alpha-mannosidosis

Alpha-mannosidosis is a rare childhood disease which causes symptoms such as mental retardation or hearing loss and is linked to a lower life expectancy. A European research team headed by Professor Paul Saftig from Christian-Albrechts-Universit-t zu Kiel has developed a form of therapy as part of the Alpha-Man project, which will receive around six million euros from the European Union for its next stage of trials.

9 Dec 2010

Medical News

Winners of 2010 Quality and Innovation Awards announced

St. Jude Medical announces advanced technologies for streamlined workflow in EP lab

Downstream cancer care linked to complications during surgery

Weightlifting program does not increase risk of lymphedema in breast cancer survivors

Research into hospital bed technology could soon represent giant leap forward in patient care

Agilent, UC Davis to develop MassCode PCR technology for identifying food-borne pathogens

Haitian health ministry says more than 2,000 have died from cholera; Report identifies outbreak's source, some dispute findings

Capitol Hill: Upton to lead energy and commerce; Dems unveil budget bill, Senate considers 9/11 worker health bill

Enbrel outperforms Humira in treating newly diagnosed RA patients: Report

Teva, Active Biotech report positive initial results from laquinimod Phase III study in multiple sclerosis

Medisafe 1 Technologies demonstrates syringe locking device at Israel's National Ministry of Health

Research findings could lead to new therapies to correct neurological disorders

XenoPort prices underwritten offering of common stock

Media examines efforts to protect patients in Africa from counterfeit medications

Urgent reform of Medicaid-financed community care for ADHD children needed

VIRxSYS presents study results of VRX1116 at HIV DART 2010

Dietitians prefer olive oil as food oil of choice

Report examines African government funding for child development

Arizona State Dem. lawmakers push for restoring Medicaid transplant money

European researchers develop new form of therapy for Alpha-mannosidosis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News